v3.26.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   87,452,835      
Beginning balance at Dec. 31, 2024 $ 59,077 $ 9 $ 1,506,315 $ (80) $ (1,447,167)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 32,410   32,410    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   1,883,440      
Issuance of common stock under the equity incentive plan and proceeds from exercise 8,796   8,796    
Employee stock purchase program purchase and expense (in shares)   120,351      
Employee stock purchase program expense 2,530   2,530    
Induced conversion on 2029 Notes 0        
Foreign currency translation adjustments (702)     (702)  
Unrealized (loss) gain on marketable debt securities (272)     (272)  
Net (loss) income (28,275)       (28,275)
Ending balance (in shares) at Sep. 30, 2025   89,456,626      
Ending balance at Sep. 30, 2025 73,564 $ 9 1,550,051 (1,054) (1,475,442)
Beginning balance (in shares) at Jun. 30, 2025   89,102,347      
Beginning balance at Jun. 30, 2025 32,747 $ 9 1,534,698 (812) (1,501,148)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 10,901   10,901    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   354,279      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 4,090   4,090    
Employee stock purchase program purchase and expense (in shares) 0        
Employee stock purchase program expense $ 362   362    
Foreign currency translation adjustments (284)     (284)  
Unrealized (loss) gain on marketable debt securities 42     42  
Net (loss) income 25,706       25,706
Ending balance (in shares) at Sep. 30, 2025   89,456,626      
Ending balance at Sep. 30, 2025 73,564 $ 9 1,550,051 (1,054) (1,475,442)
Beginning balance (in shares) at Dec. 31, 2025   90,922,868      
Beginning balance at Dec. 31, 2025 114,828 $ 9 1,588,721 (1,189) (1,472,713)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation $ 59,893   59,893    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares) 1,371,230 4,671,815      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 60,461   60,461    
Employee stock purchase program purchase and expense (in shares)   78,782      
Employee stock purchase program expense 3,835   3,835    
Induced conversion on 2029 Notes (91,340)   (91,340)    
Foreign currency translation adjustments 1,367     1,367  
Unrealized (loss) gain on marketable debt securities (2,224)     (2,224)  
Net (loss) income (124,236)       (124,236)
Ending balance (in shares) at Sep. 30, 2026   95,673,465      
Ending balance at Sep. 30, 2026 22,584 $ 9 1,621,570 (2,046) (1,596,949)
Beginning balance (in shares) at Jun. 30, 2026   94,174,767      
Beginning balance at Jun. 30, 2026 24,522 $ 9 1,570,242 (1,117) (1,544,612)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share based compensation 22,885   22,885    
Issuance of common stock under the equity incentive plan and proceeds from exercise (in shares)   1,498,698      
Issuance of common stock under the equity incentive plan and proceeds from exercise $ 27,891   27,891    
Employee stock purchase program purchase and expense (in shares) 0        
Employee stock purchase program expense $ 552   552    
Foreign currency translation adjustments 450     450  
Unrealized (loss) gain on marketable debt securities (1,379)     (1,379)  
Net (loss) income (52,337)       (52,337)
Ending balance (in shares) at Sep. 30, 2026   95,673,465      
Ending balance at Sep. 30, 2026 $ 22,584 $ 9 $ 1,621,570 $ (2,046) $ (1,596,949)